Patrick G. Fisher is a senior healthcare executive with 26 years of experience transforming and scaling global medical device businesses. He has a proven track record of driving profitable revenue growth, expanding EBITDA and operating income, leading complex M&A integrations, and building high-performing commercial and operational teams within publicly traded organizations. Fisher currently serves as president, Global Biologics and Limb Reconstruction at Orthofix, where he holds full P&L responsibility for the Biologics and Limb Reconstruction business units. He has successfully launched a new Limb Reconstruction category, exceeded revenue and EBITDA targets, and delivered double-digit U.S. growth. In January 2026, he assumed leadership of the $145M Global Biologics business. Previously, Fisher was vice president and general manager of Foot and Ankle at Stryker, managing a $972 million business within the Trauma and Extremities Division. He led the integration of Wright Medical following Stryker’s $5.4B acquisition—one of only four executives retained post-acquisition—and helped deliver sustained growth and margin expansion while transforming the commercial model from distributor-based to fully direct. Prior to Stryker, Fisher spent 18 years at Wright Medical Technology, ultimately serving as president of Lower Extremity and Biologics, where he improved EBITDA leverage, accelerated innovation-driven growth, and played a key role in increasing the company market capitalization by more than $4B. Fisher is known for his integrity-driven leadership style, candid team and board engagement, and commitment to talent development. He holds an MBA from the University of Memphis and a BA in International Studies from Rhodes College.